- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06580678
A Study to Evaluate Physiologic Dentin Regeneration and Safety of KH001 in the Administration of Erupted Wisdom Tooth With Dentin Caries
January 11, 2026 updated by: Byoung-Moo Seo
A Clinical Study to Evaluate Physiologic Dentin Regeneration When KH001 Was Administration to Erupted Wisdom Tooth With Dentin Caries
The purpose of this study is to evaluate physiologic dentin regeneration and safety of KH001 in the administration of erupted wisdom tooth with dentin caries
Study Overview
Detailed Description
The design is a single site, double-blind, randomized study.
Phase 2 study to evaluate physiologic dentin regeneration and safety of KH001.
The total duration of the study will be approximately 5 to 9 weeks.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, South Korea, 03080
- Seoul National University Dental Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Is between 19 and 35 of age by the time of the screening
- Has signed written informed consent in the study
- Subject who either have no pain in the affected tooth, or can endure pain until the day of tooth extraction
Exclusion Criteria:
- Is allergic to the active ingredient or other ingredients used in the investigational product
- Have participated in another clinical study within 30 days from screening visit and have a history of administration/application of investigational product/device
- Is judged by the investigator as ineligible for participation for other reasens
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
KH001
|
topical application of KH001
|
|
Placebo Comparator: Group B
Water for Injection
|
topical application of Water for Injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of physiological dentin formation
Time Frame: Week 5
|
Histological analysis after wisdom tooth extraction by histological analysis
|
Week 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse Events
Time Frame: Up to 9 weeks
|
The adverse event name, onset date, resolution date, and other relevant details will be recorded until end of visit.
|
Up to 9 weeks
|
|
Oral soft/hard tissue examination
Time Frame: Up to 9 weeks
|
Evaluation of oral condition by referring to maximum probing depth.
|
Up to 9 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 6, 2024
Primary Completion (Actual)
May 7, 2025
Study Completion (Actual)
May 7, 2025
Study Registration Dates
First Submitted
August 11, 2024
First Submitted That Met QC Criteria
August 29, 2024
First Posted (Actual)
August 30, 2024
Study Record Updates
Last Update Posted (Actual)
January 13, 2026
Last Update Submitted That Met QC Criteria
January 11, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KH-002-I201
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dentin Caries
-
Hacettepe UniversityRecruitingDeep Caries | Dentin CariesTurkey
-
Albert MehlNot yet recruitingCaries; Initial | Caries Assessment | Caries; DentinSwitzerland
-
Recep Tayyip Erdogan UniversityCompleted
-
Recep Tayyip Erdogan UniversityCompleted
-
Recep Tayyip Erdogan UniversityRecruitingDentin CariesTurkey (Türkiye)
-
Necmettin Erbakan Universitynecmettin erbakan university Scientific Research Projects (BAP)Completed
-
Mansoura UniversityCompletedCaries Class II | Caries; DentinEgypt
-
Recep Tayyip Erdogan UniversityRecruitingDentin CariesTurkey (Türkiye)
-
Cairo UniversityCompleted
-
Al-Azhar UniversityCompleted
Clinical Trials on KH001
-
HysensBio Co., LtdCompletedDentin HypersensitivityKorea, Republic of
-
HysensBio Co., LtdThe Forsyth InstituteCompletedDentin HypersensitivityUnited States
-
HysensBio Co., LtdCompletedDentin SensitivityKorea, Republic of